A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009)

Clinical trial NCT01993329 · COMPLETED

Trial details

NCT number

NCT01993329

Sponsor

Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-12-16

Primary completion

2014-02-20

Enrollment

20

View on ClinicalTrials.gov